Equities

Shouyao Holdings Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Shouyao Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)39.01
  • Today's Change-1.59 / -3.92%
  • Shares traded2.15m
  • 1 Year change+19.92%
  • Beta1.6062
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Shouyao Holdings Co Ltd is a China-based company mainly engaged in the research and development of innovative drugs. The Company's main business is the research and development of small molecule innovative drugs in the clinical stage. The Company's main products include anaplastic lymphoma kinase (ALK) kinase inhibitors, selective inhibitors and others. The Company's pharmaceutical products are used in key tumor indications such as non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, thyroid cancer, ovarian cancer, and leukemia, as well as disease areas such as type II diabetes. The Company mainly operates in the domestic market.

  • Revenue in CNY (TTM)2.14m
  • Net income in CNY-206.73m
  • Incorporated2016
  • Employees178.00
  • Location
    Shouyao Holdings Co LtdBlock 15Yuquan Huigu Science and Technology ParkBEIJING 100195ChinaCHN
  • Phone+86 1 088857906
  • Fax+86 1 088853760
  • Websitehttp://www.shouyaoholding.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Xinjiang Bai Hua Cun Pharma Tech Co Ltd393.73m50.20m3.59bn731.0071.384.52--9.110.13070.13071.022.060.35031.941.88538,619.704.47-4.606.16-6.3851.8224.7512.75-16.331.81--0.00--4.468.04219.753.82-0.975--
Qingdao Vland Biotech INC1.39bn83.57m4.02bn1.57k48.332.27--2.890.3290.3295.507.010.45853.893.65--3.764.846.116.9444.1945.528.209.540.877--0.264832.3510.169.30-22.39-4.23-2.71-6.89
Hinova Pharmaceuticals Inc23.61m-144.57m4.56bn173.00--4.15--193.34-1.46-1.460.238411.120.01712.375.59136,467.70-10.45-26.09-11.68-29.7495.50---612.36-78,863.606.90--0.0883-----38.6732.18--139.77--
Shanghai Aladdin Biochemical Tech Co Ltd599.98m83.95m5.33bn652.0064.424.99--8.880.24850.24851.783.210.27850.42184.55920,216.305.047.816.908.6062.2160.6118.0924.951.539.150.354148.3332.4420.5515.079.1741.61--
Hangzhou Alltest Biotech Co Ltd881.63m294.76m5.48bn969.0018.551.40--6.213.723.7211.1249.210.20982.386.39909,839.107.0219.187.5721.6655.0057.7933.4738.828.34--0.009335.1414.8329.1367.5030.9971.01--
Bide Pharmatech Co Ltd1.27bn153.31m5.49bn738.0034.352.74--4.321.761.7614.4922.030.51670.88045.251,720,520.006.247.027.528.2943.3042.1612.0713.132.78--0.105548.730.929834.697.17--80.65--
Shouyao Holdings Co Ltd2.14m-206.73m6.04bn178.00--9.23--2,818.82-1.39-1.390.01444.400.00250.03660.262512,033.88-23.67-32.53-27.20-36.2595.7499.43-9,651.03-3,370.016.42--0.0044---24.61-19.34-14.21--49.71--
Jiangsu Yahong Meditech Co Ltd279.02m-362.17m6.93bn391.00--3.91--24.83-0.642-0.6420.49333.100.12511.164.19713,603.90-16.84-14.30-19.15-15.0172.2273.78-134.65-703.804.96--0.1545--1,365.55--4.09--50.48--
GemPharmatech Co Ltd752.70m121.51m7.22bn1.58k58.573.28--9.590.30070.30071.865.370.28074.511.88476,993.404.537.695.428.9661.8468.1716.1425.583.17--0.129521.9410.3928.94-30.8925.8820.02--
Beijing Sun-Novo Pharma Research Co Ltd1.02bn133.01m7.73bn1.36k56.816.65--7.591.211.219.2310.380.474535.481.28653,956.406.0411.3910.4918.8248.6053.3112.7219.661.789.970.335511.2915.7035.80-3.9830.213.50--
Data as of Feb 11 2026. Currency figures normalised to Shouyao Holdings Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

21.69%Per cent of shares held by top holders
HolderShares% Held
Penghua Fund Management Co., Ltd.as of 30 Jun 20255.41m9.96%
ICBC UBS Asset Management Co. Ltd.as of 30 Jun 20252.64m4.86%
Da Cheng Fund Management Co., Ltd.as of 30 Jun 20251.34m2.47%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20251.17m2.16%
China Universal Asset Management Co., Ltd.as of 30 Jun 2025350.41k0.65%
SSgA Funds Management, Inc.as of 08 Jan 2026216.86k0.40%
Yinhua Fund Management Co., Ltd.as of 30 Jun 2025200.00k0.37%
CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025168.63k0.31%
Orient Fund Management Co., Ltd.as of 30 Jun 2025157.85k0.29%
China Fund Management Co., Ltd.as of 30 Jun 2025125.00k0.23%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.